studies on tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Diabetes Distilled: “Twincretin” tirzepatide significantly

74% of people who quit a GLP-1 plan to restart within a year (NPR, 2026)

Explore plans at Laser Beauty Works in Denver.

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss

Norovirus is a very contagious virus that causes an inflammation or infection of the stomach and intestines, often called acute gastroenteritis.

This meta-analysis suggests that GLP-1 RA reduce kidney disease progression in T2D or overweight/obesity regardless of CKD status

In recent years, with the updates in both basic and clinical studies on LNM and the application of advanced medical technologies, much progress has been made in the understanding of the mechanisms of LNM and the strategies for diagnosis and treatment of LNM